Reshma Rageevakumar
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.
Journal: Hereditary cancer in clinical practice
Published: April 01, 2026
Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.
Journal: Genome medicine
Published: July 29, 2025
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.
Journal: The New England journal of medicine
Published: April 11, 2025
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.
Journal: European urology oncology
Published: December 04, 2023
Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes.
Journal: BJC reports
Published: September 19, 2023
Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
Journal: European urology
Published: July 17, 2022
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.
Journal: BJU international
Published: December 17, 2020
Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Journal: European urology
Published: April 23, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026